SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia informs about outcome of board meeting

30 Jan 2024 Evaluate
In terms of Regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’) and SEBI Circular No. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 (as amended), Jubilant Ingrevia has informed that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2023 were approved by the Board of Directors of the Company at its meeting held today at 11:45 am and concluded at 2:45pm. Pursuant to applicable provisions of the Listing Regulations, the company has enclosed: The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2023, Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter, Declaration for unmodified Auditors’ Report (Standalone and Consolidated) and The Board has declared an Interim Dividend of Rs 2.50 per equity share of Re 1 each on the paid-up Equity Share capital of the Company for the Financial Year 2023-24. Further, in terms of Regulation 42 of the Listing Regulations, the Board has fixed Friday, February 9, 2024 as ‘Record Date’ for the purpose of ascertaining eligibility of the shareholders for payment of Interim Dividend. The Interim Dividend will be paid/ dispatched on or before February 28, 2024.

The above information is a part of company’s filings submitted to BSE.

Jubilant Ingrevia Share Price

667.55 1.75 (0.26%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3653.10
Tata Chemicals 704.05
SRF 2464.40
Pidilite Inds. 1390.15
Deepak Nitrite 1537.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×